These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6334249)

  • 1. [Connectivitis-like pathologies. Incomplete or initial connectivitis?].
    Carotti A; Oggioni C; Rosati S; Gasparini M; Carotti A
    Minerva Med; 1984 Oct; 75(38):2207-12. PubMed ID: 6334249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysthyroidism and connective pathology].
    Schachter I; Antignani PL
    Minerva Cardioangiol; 2006 Dec; 54(6):811-4. PubMed ID: 17396337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
    Williams HJ; Alarcón GS; Neuner R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; Polisson RP; Willkens RF; Yarboro C; Morgan J; Egger MJ; Ward JR
    J Rheumatol; 1998 Feb; 25(2):261-8. PubMed ID: 9489817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of anti-F-actin antibodies in a French multicenter study.
    Chretien-Leprince P; Ballot E; Andre C; Olsson NO; Fabien N; Escande A; Oksman F; Dubuquoi S; Jego S; Goetz J; Chevailler A; Sanmarco M; Humbel RL; Johanet C
    Ann N Y Acad Sci; 2005 Jun; 1050():266-73. PubMed ID: 16014542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic contribution and current concepts in nailfold capillary microscopy in rheumatology].
    Caleiro MT
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):104-10. PubMed ID: 9435405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud phenomenon in childhood: review and progress control in eight cases].
    González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
    An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical importance of antinuclear antibodies].
    Dabelić N; Cikes N
    Lijec Vjesn; 1997; 119(8-9):236-42. PubMed ID: 9481891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II antigens associated with anti-Ki autoantibody positive connective tissue disease in Japanese.
    Matsunaga K; Yawata M; Tsuji T; Tani K
    J Rheumatol; 1998 Jul; 25(7):1446-7. PubMed ID: 9676789
    [No Abstract]   [Full Text] [Related]  

  • 16. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the clinical immunology laboratory in the diagnosis and monitoring of connective tissue diseases.
    Aziz KA; Faizal AA
    Saudi Med J; 2004 Dec; 25(12):1796-807. PubMed ID: 15711644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
    Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
    J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of antinuclear antibodies].
    Swaak AJ
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP; Curry NH; Mallory JH; Waller MV
    J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.